Cargando…

Serum IgG N-glycans act as novel serum biomarkers of ankylosing spondylitis

Detalles Bibliográficos
Autores principales:	Wang, Jingrong, Wang, Canjian, Liang, Yong, Pan, Hudan, Jiang, Zhihong, Li, Zhanguo, Li, Yuhui, Xia, Liangyong, Liu, Wei, Zhang, Xiao, Liu, Zhilong, Jiang, Min, Liu, Ju, Zhou, Hua, Liu, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517803/ https://www.ncbi.nlm.nih.gov/pubmed/30442647 http://dx.doi.org/10.1136/annrheumdis-2018-213815

Ejemplares similares

Serum galectin‐3 concentrations in patients with ankylosing spondylitis
por: Cao, Ming‐Yu, et al.
Publicado: (2019)

The Value of Serum Amyloid A in the Diagnosis and Management of Ankylosing Spondylitis
por: Hu, Qi-Lei, et al.
Publicado: (2021)

N-glycans from serum IgG and total serum glycoproteins specific for endometriosis
por: Kovács, Zsuzsanna, et al.
Publicado: (2023)

Competition between Serum IgG, IgM, and IgA Anti-Glycan Antibodies
por: Muthana, Saddam M., et al.
Publicado: (2015)

Factors Affecting Anti-Glycan IgG and IgM Repertoires in Human Serum
por: Muthana, Saddam M., et al.
Publicado: (2016)

Isolation of IgG Antibodies to Toxocara in Ankylosing Spondylitis Patients with Acute Anterior Uveitis
por: Jiménez-Balderas, Francisco-Javier, et al.
Publicado: (2014)

Serum Prolidase Activity in Ankylosing Spondylitis and Rheumatoid Arthritis
por: Uçar, Demet, et al.
Publicado: (2013)

Serum chitotriosidase and neopterin levels in patients with ankylosing spondylitis
por: Yavuz, Ferdi, et al.
Publicado: (2019)

Development of a Multiplex Glycan Microarray Assay and Comparative Analysis of Human Serum Anti-Glycan IgA, IgG, and IgM Repertoires
por: Durbin, Sarah V., et al.
Publicado: (2018)

Glycomic Signatures on Serum IgGs for Prediction of Postvaccination Response
por: Wang, Jing-Rong, et al.
Publicado: (2015)

Detection of serum IgM and IgG for COVID-19 diagnosis
por: Zhong, Ling, et al.
Publicado: (2020)

Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients
por: Erdem, Fazile Hatipoglu, et al.
Publicado: (2010)

Discovery of Candidate Serum Proteomic and Metabolomic Biomarkers in Ankylosing Spondylitis
por: Fischer, Roman, et al.
Publicado: (2012)

A method to identify trace sulfated IgG N-glycans as biomarkers for rheumatoid arthritis
por: Wang, Jing-Rong, et al.
Publicado: (2017)

Serum IL-6 correlates with axial mobility index (Bath Ankylosing Spondylitis Metrology Index) in Brazilian patients with ankylosing spondylitis
por: Rabelo, Cristina F, et al.
Publicado: (2018)

IgG Galactosylation status combined with MYOM2-rs2294066 precisely predicts anti-TNF response in ankylosing spondylitis
por: Liu, Jing, et al.
Publicado: (2019)

IgE glycans promote anti-IgE IgG autoantibodies that facilitate IgE serum clearance via Fc Receptors
por: Plattner, Kevin, et al.
Publicado: (2022)

Mechanism of Hip Arthropathy in Ankylosing Spondylitis: Abnormal Myeloperoxidase and Phagosome
por: Yu, Chaojie, et al.
Publicado: (2021)

Serum Metabolomics Signatures Associated With Ankylosing Spondylitis and TNF Inhibitor Therapy
por: Ou, Jiayong, et al.
Publicado: (2021)

Serum DKK-1 level in the development of ankylosing spondylitis and rheumatic arthritis: a meta-analysis
por: Zhang, Li, et al.
Publicado: (2016)

RNA sequencing and bioinformatics analysis of differentially expressed genes in the peripheral serum of ankylosing spondylitis patients
por: Bie, Yongchen, et al.
Publicado: (2023)

Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy
por: Zhao, Yan-feng, et al.
Publicado: (2017)

Clinical significance of the detection of serum IgG4 and IgG4/IgG ratio in patients with thyroid-associated ophthalmopathy
por: Zhao, JianGuo, et al.
Publicado: (2023)

Serum IgA, IgM, and IgG responses in COVID-19
por: Ma, Huan, et al.
Publicado: (2020)

Serum DKK-1 level in ankylosing spondylitis: insights from meta-analysis and Mendelian randomization
por: Fang, Xi, et al.
Publicado: (2023)

Ankylosing spondylitis
Publicado: (1980)

Ankylosing spondylitis
por: Edavalath, Mukesh
Publicado: (2010)

Ankylosing Spondylitis
por: Whitfield, A. G. W.
Publicado: (1976)

Ankylosing Spondylitis
por: Ebrahimiadib, Nazanin, et al.
Publicado: (2021)

Serum markers associated with clinical improvement in patients with ankylosing spondylitis treated with golimumab
por: Wagner, Carrie, et al.
Publicado: (2011)

Clinical Significance of Elevated Serum Caspase-1 Levels in Patients With Ankylosing Spondylitis
por: Kim, Sang-Hyon, et al.
Publicado: (2022)

Serum RANKL levels in Chinese patients with ankylosing spondylitis: a meta-analysis
por: Ni, Feifei, et al.
Publicado: (2021)

Altered glycosylation profiles of serum IgG in Takayasu arteritis
por: Liu, Lingyu, et al.
Publicado: (2023)

Temporal reproducibility of IgG and IgM autoantibodies in serum from healthy women
por: Clendenen, T. V., et al.
Publicado: (2022)

Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels
por: MacGlashan, Donald, et al.
Publicado: (2021)

Reply to ‘Trace N-glycans including sulphated species may originate from various plasma glycoproteins and not necessarily IgG’
por: Wang, Jing-Rong, et al.
Publicado: (2018)

Serum Amyloid A as a Useful Indicator of Disease Activity in Patients with Ankylosing Spondylitis
por: Jung, Sang Youn, et al.
Publicado: (2007)

Elevated serum interleukin-23 levels in ankylosing spondylitis patients and the relationship with disease activity
por: Ugur, Mahir, et al.
Publicado: (2015)

Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study
por: Perrotta, Fabio Massimo, et al.
Publicado: (2018)

Evaluation of serum thiol/disulfide homeostasis in patients with ankylosing spondylitis by a novel method
por: Baykara, Rabia Aydogan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lmrgig4oq8hrqv6h7eb5k8sdo8